BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35959811)

  • 1. [Bisphosphonate-induced ocular and orbital inflammation].
    Jakobsen TS; Funding M
    Ugeskr Laeger; 2022 Jul; 184(28):. PubMed ID: 35959811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular Side Effects of Bisphosphonates: A Review of Literature.
    Chartrand NA; Lau CK; Parsons MT; Handlon JJ; Ronquillo YC; Hoopes PC; Moshirfar M
    J Ocul Pharmacol Ther; 2023; 39(1):3-16. PubMed ID: 36409537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postmarketing surveillance rates of uveitis and scleritis with bisphosphonates among a national veteran cohort.
    French DD; Margo CE
    Retina; 2008 Jun; 28(6):889-93. PubMed ID: 18536608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aminobisphosphonate-associated orbital and ocular inflammatory disease.
    Keren S; Leibovitch I; Ben Cnaan R; Neudorfer M; Fogel O; Greenman Y; Shulman S; Zur D; Habot-Wilner Z
    Acta Ophthalmol; 2019 Aug; 97(5):e792-e799. PubMed ID: 30816018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bisphosphonate-associated orbital inflammatory disease and uveitis anterior--a case report and review.
    Böni C; Kordic H; Chaloupka K
    Klin Monbl Augenheilkd; 2013 Apr; 230(4):367-9. PubMed ID: 23629782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphosphonate-Induced Orbital Inflammation: A Case Series and Review.
    Pirbhai A; Rajak SN; Goold LA; Cunneen TS; Wilcsek G; Martin P; Leibovitch I; Selva D
    Orbit; 2015; 34(6):331-5. PubMed ID: 26540241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisphosphonate-associated scleritis: a case report and review.
    Leung S; Ashar BH; Miller RG
    South Med J; 2005 Jul; 98(7):733-5. PubMed ID: 16108245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory ocular adverse events with the use of oral bisphosphonates: a retrospective cohort study.
    Etminan M; Forooghian F; Maberley D
    CMAJ; 2012 May; 184(8):E431-4. PubMed ID: 22470169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Case Series and Review of Bisphosphonate-associated Orbital Inflammation.
    Lefebvre DR; Mandeville JT; Yonekawa Y; Arroyo JG; Torun N; Freitag SK
    Ocul Immunol Inflamm; 2016; 24(2):134-9. PubMed ID: 25153041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-induced ocular inflammation.
    Samalia P; Sims J; Niederer R
    N Z Med J; 2020 Dec; 133(1527):83-94. PubMed ID: 33332330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postmarketing surveillance rates of uveitis and scleritis with bisphosphonates among a national veteran cohort.
    Fraunfelder FW; Winthrop K; Suhler E; Choi D; Fraunfelder FT
    Retina; 2009 Feb; 29(2):285-6; author reply 286-7. PubMed ID: 19202428
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute bilateral uveitis and right macular edema induced by a single infusion of zoledronic acid for the treatment of postmenopausal osteoporosis as a substitution for oral alendronate: a case report.
    Tian Y; Wang R; Liu L; Ma C; Lu Q; Yin F
    BMC Musculoskelet Disord; 2016 Feb; 17():72. PubMed ID: 26867651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisphosphonate-induced orbital inflammation: more common than once thought?
    Chehade LK; Curragh D; Selva D
    Osteoporos Int; 2019 May; 30(5):1117-1120. PubMed ID: 30675627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffuse ocular and orbital inflammation after zoledronate infusion-case report and review of the literature.
    Umunakwe OC; Herren D; Kim SJ; Kohanim S
    Digit J Ophthalmol; 2017; 23(4):18-21. PubMed ID: 29403337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisphosphonate-associated adverse events.
    Papapetrou PD
    Hormones (Athens); 2009; 8(2):96-110. PubMed ID: 19570737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute retinal pigment epithelial detachment secondary to pamidronate administration.
    Dasanu CA; Alexandrescu DT
    J Oncol Pharm Pract; 2009 Jun; 15(2):119-21. PubMed ID: 18818218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisphosphonates: uveitis and scleritis.
    Prescrire Int; 2013 May; 22(138):128. PubMed ID: 23819179
    [No Abstract]   [Full Text] [Related]  

  • 18. Risk of atypical femoral fractures and osteonecrosis of the jaw associated with alendronate use compared with other oral bisphosphonates.
    Kharazmi M; Hallberg P; Warfvinge G; Michaëlsson K
    Rheumatology (Oxford); 2014 Oct; 53(10):1911-3. PubMed ID: 25099769
    [No Abstract]   [Full Text] [Related]  

  • 19. Bilateral Acute Anterior Uveitis and Conjunctivitis following Intravenous Zoledronic Acid.
    Chatterjee S; Agrawal D
    J Assoc Physicians India; 2017 Jul; 65(7):110-111. PubMed ID: 28792180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical case of the month. Bilateral optic neuropathy secondary to biphosphonate therapy].
    Lespagnard S; Bonnet S; Betz P
    Rev Med Liege; 2010; 65(7-8):434-6. PubMed ID: 20857699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.